IRELAND'S first stem cell facility will begin clinical trials this year, with the life-changing therapies expected to be widely available within five years.
Professor Frank Barry, scientific director of CCMI, who has worked on the project for the past 10 years, said the opening of the new facility was a major step forward for stem cell use in Ireland.
He revealed that the first clinical trial would begin this year for diabetic patients with lower limb ulcers, which can lead to amputation.
Researchers believe stem cell therapy will stimulate regrowth of the interrupted blood vessels so that their limb will be saved. It will work exclusively with adult stem cells.